| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |